Can reducing planning safety margins broaden the inclusion criteria for lung stereotactic ablative body radiotherapy?

INTRODUCTION: Stereotactic ablative body radiotherapy (SABR) is currently indicated for inoperable, early‐stage non‐small cell lung carcinoma (NSCLC). Advancements in image‐guidance technology continue to improve treatment precision and enable reductions in planning safety margins. We investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghandourh, Wsam, Batumalai, Vikneswary, Boxer, Miriam, Holloway, Lois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424332/
https://www.ncbi.nlm.nih.gov/pubmed/33934559
http://dx.doi.org/10.1002/jmrs.469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424332/
https://www.ncbi.nlm.nih.gov/pubmed/33934559
http://dx.doi.org/10.1002/jmrs.469

Ejemplares similares